Innovative Science
Unlocking a Universe of
Therapeutic Breakthroughs

Through the Door

Sevion is a biopharmaceutical company which discovers and develops entirely new therapeutic classes for the treatment of cancer and immunological diseases. The Company’s product candidates are derived from multiple key proprietary technology platforms: cell-based arrayed antibody discovery, ultralong antibody scaffolds and chimerasome nanocages. Sevion has leveraged these technologies to build a pipeline of innovative proprietary and partnered product candidates.